Biocomm

Biocomm is an Australian life sciences business development and seed finance company that focuses on the commercialization of biotechnology and medical research. Established in 2001, the firm provides strategic advisory, licensing, and technology transfer services to universities, research institutes, and biotech companies. Biocomm manages a seed capital pool and has been a key player in launching several startups, including CNSBio, which focuses on pain management therapies. The company operates as a critical intermediary in the Asia-Pacific region, facilitating deals between local innovators and global pharmaceutical partners.